[1] |
Xiao-jing CHENG,Dong JIANG,Lian-hai ZHANG,Jiang-hua WANG,Ya-zhen LI,Jia-hui ZHAI,Bao-qi YAN,Lu-lu ZHANG,Xing-wang XIE,Zi-yu LI,Jia-fu JI.
Preclinical study of T cell receptor specifically reactive with KRAS G12V mutation in the treatment of malignant tumors
[J]. Journal of Peking University (Health Sciences), 2022, 54(5): 884-895.
|
[2] |
Li ZHANG,Ji-fang GONG,Hong-ming PAN,Yu-xian BAI,Tian-shu LIU,Ying CHENG,Ya-chi CHEN,Jia-ying HUANG,Ting-ting XU,Fei-jiao GE,Wan-ling HSU,Jane SHI,Xi-chun HU,Lin SHEN.
Atezolizumab therapy in Chinese patients with locally advanced or metastatic solid tumors: An open-label, phase Ⅰ study
[J]. Journal of Peking University (Health Sciences), 2022, 54(5): 971-980.
|
[3] |
DING Ting-ting,ZENG Chu-xiong,HU Li-na,YU Ming-hua.
Establishment of a prediction model for colorectal cancer immune cell infiltration based on the cancer genome atlas (TCGA) database
[J]. Journal of Peking University (Health Sciences), 2022, 54(2): 203-208.
|
[4] |
GU Yang-chun,LIU Ying,XIE Chao,CAO Bao-shan.
Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases
[J]. Journal of Peking University (Health Sciences), 2022, 54(2): 369-375.
|
[5] |
.
[J]. Journal of Peking University (Health Sciences), 2020, 52(3): 597-602.
|
[6] |
.
[J]. Journal of Peking University (Health Sciences), 2020, 52(2): 204-206.
|
[7] |
Yan TIAN,Jun ZHU.
Relationship between p53 rs1625895 polymorphism and prognosis in diffuse large B-cell lymphoma
[J]. Journal of Peking University(Health Sciences), 2019, 51(5): 791-796.
|
[8] |
WU Peng-hui, XIE Yao, ZHAO Wei-hong, HUA Ying, SUN Qing, LI Shuo, WU Ye, LU Xin-tian.
Clinical characteristics analysis of children with reversible posterior leukoen-cephalopathy syndrome during the treatment of hematological tumor
[J]. Journal of Peking University(Health Sciences), 2018, 50(4): 662-665.
|
[9] |
ZHU Yan,SHI Yong-jin,ZHAO Yu-liang, ZHU Ping.
Topoisomerase inhibitor upregulates MICA/B expression in breast cancer cells through ATM/ATR and NF-κB pathway
[J]. Journal of Peking University(Health Sciences), 2018, 50(2): 318-325.
|
[10] |
YE Ke-qiang, HUANG Ming-wei, LI Jun-li, TANG Jin-tian, ZHANG Jian-guo.
Simulation of dose distribution in bone medium of 125I photon emitting source with Monte Carlo method
[J]. Journal of Peking University(Health Sciences), 2018, 50(1): 131-135.
|
[11] |
SUN Hai-tao, YANG Rui-jie, JIANG Ping, JIANG Wei-juan, LI Jin-na, MENG Na, WANG Jun-jie.
Dosimetric analysis of volumetric modulated arc therapy and intensity modulated radiotherapy for patients undergone breast-conserving operation
[J]. Journal of Peking University(Health Sciences), 2018, 50(1): 188-192.
|
[12] |
LIU Jing-wei, LU Xu, YANG Zhao-min, DENG Li-juan, YANG Lin.
Immune effects of specific CTLs response induced by dendritic cells pulsed with NY-ESO-1 peptide
[J]. Journal of Peking University(Health Sciences), 2017, 49(5): 840-846.
|
[13] |
LIU Jing-wei, LU Xu, YANG Zhao-min, DENG Li-juan, YANG Lin.
Immune effects of specific CTLs response induced by dendritic cells pulsed with NY-ESO-1 peptide
[J]. Journal of Peking University(Health Sciences), 0, (): 840-846.
|
[14] |
GUO Fu-xin, JIANG Yu-liang, JI Zhe, PENG Ran, SUN Hai-tao, WANG Jun-jie.
3D printed template-assisted and computed tomography image-guided 125-iodine seed implantation for supraclavicular metastatic tumor: a dosimetric study
[J]. Journal of Peking University(Health Sciences), 2017, 49(3): 506-511.
|
[15] |
JIANG Ping, ZHOU Shun,WANG Jun-jie, YANG Rui-jie, LIU Zi-yi, JIANG Shu-kun, WANG Wei.
Errors in six degree-of-freedom pose estimation of spine tumors assessed by image guided radiotherapy
[J]. Journal of Peking University(Health Sciences), 2015, 47(6): 952-956.
|